Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secondary aldosteronism

D B Corry1, M L Tuck

  • 1Department of Medicine, Olive View Medical Center, Sylmar California, USA.

Endocrinology and Metabolism Clinics of North America
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibrinogen and lipopolysaccharide promote TLR4-dependent glucocorticoid resistance in airway mycosis-driven allergic airway disease.

Mucosal immunology·2026
Same author

Protective role of γδ T cells in cigarette smoke and influenza infection.

Mucosal immunology·2017
Same author

Cigarette Smoke and DNA Cleavage Promote Lung Inflammation and Emphysema.

Transactions of the American Clinical and Climatological Association·2017
Same author

Activation of C3a receptor is required in cigarette smoke-mediated emphysema.

Mucosal immunology·2014
Same author

Construction of polycompetitors for competitive PCR.

Methods in molecular medicine·2011
Same author

Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.

Mucosal immunology·2010
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Secondary aldosteronism, common in clinical settings, can be beneficial in some conditions but is often detrimental. Effective treatment requires addressing both aldosterone imbalances and underlying pathophysiologic mechanisms.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Secondary aldosteronism is prevalent in clinical practice, affecting both normotensive and hypertensive individuals.
  • Aldosterone's role varies, offering partial benefits in conditions like edema but often proving detrimental in others.

Purpose of the Study:

  • To evaluate the multifaceted impact of secondary aldosteronism across various clinical conditions.
  • To determine the efficacy of aldosterone in physiological versus pathophysiological states.

Main Methods:

  • Review of clinical literature on secondary aldosteronism.
  • Analysis of aldosterone's effects on sodium and potassium balance in different disease states.

Main Results:

Related Experiment Videos

  • Aldosterone partially restores volume and sodium in edema but causes hypokalemia.
  • In renovascular hypertension and malignant hypertension, aldosterone's impact is predominantly detrimental.
  • Pregnancy and chronic renal failure show limited or overridden benefits from hyperaldosteronism.
  • Iatrogenic causes of secondary aldosteronism generally have detrimental effects.

    • Conclusions:

    • Aldosterone functions optimally in physiological states.
    • In pathophysiological conditions, aldosterone does not fully compensate for underlying defects.
    • Therapeutic strategies must target both aldosterone dysregulation and core pathophysiologic mechanisms.